$2.15
-0.09 (-4.02%)
Open$2.14
Previous Close$2.24
Day High$2.22
Day Low$2.12
52W High$12.37
52W Low$1.81
Volume—
Avg Volume28.1K
Market Cap18.22M
P/E Ratio—
EPS$-1.87
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+802.8% upside
Current
$2.15
$2.15
Target
$19.41
$19.41
$13.09
$19.41 avg
$19.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.98M | 1.88M | 22.16M |
| Net Income | -14,501,154 | -8,253,882 | 3.56M |
| Profit Margin | -487.1% | -462.7% | 16.1% |
| EBITDA | -15,529,506 | -9,330,274 | 4.85M |
| Free Cash Flow | — | — | 3.49M |
| Rev Growth | +58.1% | +58.1% | +9.7% |
| Debt/Equity | — | — | 0.13 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |